Influence of patient race on physician prescribing decisions: A randomized on-line experiment

Saif S. Rathore, Jonathan Ketcham, G. Caleb Alexander, Andrew J. Epstein

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Prior research reports black patients have lower medication use for hypercholesterolemia, hypertension, and diabetes. Objective: To assess whether patient race influences physicians' prescribing. Design: Web-based survey including three clinical vignettes (hypercholesterolemia, hypertension, diabetes), with patient race (black, white) randomized across vignettes. Subjects: A total of 716 respondents from 5,141 eligible sampled primary care physicians (14% response rate). Interventions: None Measurements: Medication recommendation (any medication vs none, on-patent branded vs generic, and therapeutic class) and physicians' treatment adherence forecast (10-point Likert scale, 1-definitely not adhere, 10-definitely adhere). Results: Respondents randomized to view black patients (n=371) and white patients (n=345) recommend any medications at comparable rates for hypercholesterolemia (100.0% white vs 99.5% black, P=0.50), hypertension (99.7% white vs 99.5% black, P=1.00), and diabetes (99.7% white vs 99.7% black, P=1.00). Patient race influenced medication class chosen in the hypertension vignette; respondents randomized to view black patients recommended calcium channel blockers more often (20.8% black vs 3.2% white) and angiotensin-converting enzyme inhibitors less often (47.4% black vs 62.6% white) (P<0.001). Patient race did not influence medication class for hypercholesterolemia or diabetes. Respondents randomized to view black patients reported lower forecasted patient adherence for hypertension (P<0.001, mean: 7.3 black vs 7.7 white) and diabetes (P=0.05 mean: 7.4 black vs 7.6 white), but race had no meaningful influence on forecasted adherence for hypercholesterolemia (P=0.15, mean: 7.2 black vs 7.3 white). Conclusion: Racial differences in outpatient prescribing patterns for hypertension, hypercholesterolemia, and diabetes are likely attributable to factors other than prescribing decisions based on patient race.

Original languageEnglish (US)
Pages (from-to)1183-1191
Number of pages9
JournalJournal of General Internal Medicine
Volume24
Issue number11
DOIs
StatePublished - Nov 2009

Fingerprint

Physicians
Hypercholesterolemia
Hypertension
Calcium Channel Blockers
Primary Care Physicians
Patient Compliance
Angiotensin-Converting Enzyme Inhibitors
Outpatients
Surveys and Questionnaires
Therapeutics

Keywords

  • Diabetes
  • Hypercholesterolemia
  • Hypertension
  • Patient race
  • Prescription medication

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Influence of patient race on physician prescribing decisions : A randomized on-line experiment. / Rathore, Saif S.; Ketcham, Jonathan; Alexander, G. Caleb; Epstein, Andrew J.

In: Journal of General Internal Medicine, Vol. 24, No. 11, 11.2009, p. 1183-1191.

Research output: Contribution to journalArticle

Rathore, Saif S. ; Ketcham, Jonathan ; Alexander, G. Caleb ; Epstein, Andrew J. / Influence of patient race on physician prescribing decisions : A randomized on-line experiment. In: Journal of General Internal Medicine. 2009 ; Vol. 24, No. 11. pp. 1183-1191.
@article{30cf2349ec744c85a5f9e0150782188a,
title = "Influence of patient race on physician prescribing decisions: A randomized on-line experiment",
abstract = "Background: Prior research reports black patients have lower medication use for hypercholesterolemia, hypertension, and diabetes. Objective: To assess whether patient race influences physicians' prescribing. Design: Web-based survey including three clinical vignettes (hypercholesterolemia, hypertension, diabetes), with patient race (black, white) randomized across vignettes. Subjects: A total of 716 respondents from 5,141 eligible sampled primary care physicians (14{\%} response rate). Interventions: None Measurements: Medication recommendation (any medication vs none, on-patent branded vs generic, and therapeutic class) and physicians' treatment adherence forecast (10-point Likert scale, 1-definitely not adhere, 10-definitely adhere). Results: Respondents randomized to view black patients (n=371) and white patients (n=345) recommend any medications at comparable rates for hypercholesterolemia (100.0{\%} white vs 99.5{\%} black, P=0.50), hypertension (99.7{\%} white vs 99.5{\%} black, P=1.00), and diabetes (99.7{\%} white vs 99.7{\%} black, P=1.00). Patient race influenced medication class chosen in the hypertension vignette; respondents randomized to view black patients recommended calcium channel blockers more often (20.8{\%} black vs 3.2{\%} white) and angiotensin-converting enzyme inhibitors less often (47.4{\%} black vs 62.6{\%} white) (P<0.001). Patient race did not influence medication class for hypercholesterolemia or diabetes. Respondents randomized to view black patients reported lower forecasted patient adherence for hypertension (P<0.001, mean: 7.3 black vs 7.7 white) and diabetes (P=0.05 mean: 7.4 black vs 7.6 white), but race had no meaningful influence on forecasted adherence for hypercholesterolemia (P=0.15, mean: 7.2 black vs 7.3 white). Conclusion: Racial differences in outpatient prescribing patterns for hypertension, hypercholesterolemia, and diabetes are likely attributable to factors other than prescribing decisions based on patient race.",
keywords = "Diabetes, Hypercholesterolemia, Hypertension, Patient race, Prescription medication",
author = "Rathore, {Saif S.} and Jonathan Ketcham and Alexander, {G. Caleb} and Epstein, {Andrew J.}",
year = "2009",
month = "11",
doi = "10.1007/s11606-009-1077-7",
language = "English (US)",
volume = "24",
pages = "1183--1191",
journal = "Journal of General Internal Medicine",
issn = "0884-8734",
publisher = "Springer New York",
number = "11",

}

TY - JOUR

T1 - Influence of patient race on physician prescribing decisions

T2 - A randomized on-line experiment

AU - Rathore, Saif S.

AU - Ketcham, Jonathan

AU - Alexander, G. Caleb

AU - Epstein, Andrew J.

PY - 2009/11

Y1 - 2009/11

N2 - Background: Prior research reports black patients have lower medication use for hypercholesterolemia, hypertension, and diabetes. Objective: To assess whether patient race influences physicians' prescribing. Design: Web-based survey including three clinical vignettes (hypercholesterolemia, hypertension, diabetes), with patient race (black, white) randomized across vignettes. Subjects: A total of 716 respondents from 5,141 eligible sampled primary care physicians (14% response rate). Interventions: None Measurements: Medication recommendation (any medication vs none, on-patent branded vs generic, and therapeutic class) and physicians' treatment adherence forecast (10-point Likert scale, 1-definitely not adhere, 10-definitely adhere). Results: Respondents randomized to view black patients (n=371) and white patients (n=345) recommend any medications at comparable rates for hypercholesterolemia (100.0% white vs 99.5% black, P=0.50), hypertension (99.7% white vs 99.5% black, P=1.00), and diabetes (99.7% white vs 99.7% black, P=1.00). Patient race influenced medication class chosen in the hypertension vignette; respondents randomized to view black patients recommended calcium channel blockers more often (20.8% black vs 3.2% white) and angiotensin-converting enzyme inhibitors less often (47.4% black vs 62.6% white) (P<0.001). Patient race did not influence medication class for hypercholesterolemia or diabetes. Respondents randomized to view black patients reported lower forecasted patient adherence for hypertension (P<0.001, mean: 7.3 black vs 7.7 white) and diabetes (P=0.05 mean: 7.4 black vs 7.6 white), but race had no meaningful influence on forecasted adherence for hypercholesterolemia (P=0.15, mean: 7.2 black vs 7.3 white). Conclusion: Racial differences in outpatient prescribing patterns for hypertension, hypercholesterolemia, and diabetes are likely attributable to factors other than prescribing decisions based on patient race.

AB - Background: Prior research reports black patients have lower medication use for hypercholesterolemia, hypertension, and diabetes. Objective: To assess whether patient race influences physicians' prescribing. Design: Web-based survey including three clinical vignettes (hypercholesterolemia, hypertension, diabetes), with patient race (black, white) randomized across vignettes. Subjects: A total of 716 respondents from 5,141 eligible sampled primary care physicians (14% response rate). Interventions: None Measurements: Medication recommendation (any medication vs none, on-patent branded vs generic, and therapeutic class) and physicians' treatment adherence forecast (10-point Likert scale, 1-definitely not adhere, 10-definitely adhere). Results: Respondents randomized to view black patients (n=371) and white patients (n=345) recommend any medications at comparable rates for hypercholesterolemia (100.0% white vs 99.5% black, P=0.50), hypertension (99.7% white vs 99.5% black, P=1.00), and diabetes (99.7% white vs 99.7% black, P=1.00). Patient race influenced medication class chosen in the hypertension vignette; respondents randomized to view black patients recommended calcium channel blockers more often (20.8% black vs 3.2% white) and angiotensin-converting enzyme inhibitors less often (47.4% black vs 62.6% white) (P<0.001). Patient race did not influence medication class for hypercholesterolemia or diabetes. Respondents randomized to view black patients reported lower forecasted patient adherence for hypertension (P<0.001, mean: 7.3 black vs 7.7 white) and diabetes (P=0.05 mean: 7.4 black vs 7.6 white), but race had no meaningful influence on forecasted adherence for hypercholesterolemia (P=0.15, mean: 7.2 black vs 7.3 white). Conclusion: Racial differences in outpatient prescribing patterns for hypertension, hypercholesterolemia, and diabetes are likely attributable to factors other than prescribing decisions based on patient race.

KW - Diabetes

KW - Hypercholesterolemia

KW - Hypertension

KW - Patient race

KW - Prescription medication

UR - http://www.scopus.com/inward/record.url?scp=70449531468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449531468&partnerID=8YFLogxK

U2 - 10.1007/s11606-009-1077-7

DO - 10.1007/s11606-009-1077-7

M3 - Article

C2 - 19705205

AN - SCOPUS:70449531468

VL - 24

SP - 1183

EP - 1191

JO - Journal of General Internal Medicine

JF - Journal of General Internal Medicine

SN - 0884-8734

IS - 11

ER -